✦ LIBER ✦

The complex between urokinase plasminogen activator and its type-1 inhibitor in breast cancer extracts quantitated by ELISA

✍ Scribed by Anders N Pedersen; Gunilla Høyer-Hansen; Nils Brünner; Gary M Clark; Birthe Larsen; Hans S Poulsen; Keld Danø; Ross W Stephens

Book ID: 114051738
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 120 KB
Volume: 203
Category: Article
ISSN: 0022-1759
DOI: 10.1016/s0022-1759(97)00008-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

116 Elisa determination of the complex b

116 Elisa determination of the complex between urokinase plasminogen activator and its type-1 inhibitor in tumor extracts

✍ Anders N. Pedersen; Gunilla Høyer-Hansen; Nils Brünner; Gary M. Clark; Birthe La 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 131 KB

ELISA for complexes between urokinase-ty

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts

✍ Hans de Witte; Helle Pappot; Nils Brünner; Jan Grøndahl-Hansen; Gunilla Høyer-Ha 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

A sandwich-type ELISA has been developed for the assessment of complexes between urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in extracts of squamous cell lung carcinomas. The assay is based on a combination of rabbit polyclonal anti-uPA antibodies and a biotinylated mouse anti

Physiological and pathological changes o

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

✍ Hyun Cheol Chung; Sun Young Rha; Joon Oh Park; Nae Choon Yoo; Joo Hang Kim; Jae 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 670 KB

Urokinase-Type Plasminogen Activator and

Urokinase-Type Plasminogen Activator and Its Inhibitor Type 1 Predict Disease Outcome and Therapy Response in Primary Breast Cancer

✍ Nadia Harbeck; Ronald E. Kates; Manfred Schmitt; Katja Gauger; Marion Kiechle; F 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 118 KB

The complex between urokinase plasminoge

The complex between urokinase plasminogen activator (uPA) and its type-1 inhibitor (PAI-1) denotes poor disease outcome in 576 node-negative breast cancer patients

✍ P Manders; L Beex; V Tjan-Heijnen; P Span; N Grebenchtchikow; J Geurts-Moespot; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Clinical Relevance of Urokinase-Type Pla

Clinical Relevance of Urokinase-Type Plasminogen Activator, Its Receptor, and Its Inhibitor Type 1 in Endometrial Cancer

✍ Coşkun Tecimer; David L. Doering; L.Jane Goldsmith; John S. Meyer; Gazi Abdulhay 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 67 KB